Journal article
Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review
Abstract
Cutaneous melanoma is typically treated with wide local excision and, when appropriate, a sentinel node biopsy. Many patients are cured with this approach but for patients who have cancers with high risk features there is a significant risk of local and distant relapse and death. Interferon-based adjuvant therapy was recommended in the past but had modest results with significant toxicity. Recently, new therapies (immune checkpoint inhibitors …
Authors
Baetz TD; Fletcher GG; Knight G; McWhirter E; Rajagopal S; Song X; Petrella TM
Journal
Cancer Treatment Reviews, Vol. 87, ,
Publisher
Elsevier
Publication Date
July 2020
DOI
10.1016/j.ctrv.2020.102032
ISSN
0305-7372
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAntineoplastic Agents, ImmunologicalAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicHumansMelanomaMeta-Analysis as TopicMolecular Targeted TherapyNeoplasm StagingRandomized Controlled Trials as TopicRisk FactorsSkin NeoplasmsMelanoma, Cutaneous Malignant